Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000-2010.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Preventive Medicine

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amepre.2015.04.031PMID 26190198PMCID PMC6805127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sexually transmitted diseases treatment guidelines, 2015.

  2015cited by this paper
• Sexually transmitted disease surveillance 2013

  2014cited by this paper
• Declining trends in the proportion of non-viral sexually transmissible infections reported by STD clinics in the US, 2000-10.

  2014cited by this paper
• Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008

  2013cited by this paper
• The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008

  2013cited by this paper
• Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006–June 2012

  2013cited by this paper
• Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.

  2012cited by this paper
• Estimating the Direct Outpatient Medical Cost per Episode of Primary and Secondary Syphilis in the United States: Insured Population Perspective, 2003–2007

  2011cited by this paper
• Sexually transmitted diseases treatment guidelines, 2010.

  2010cited by this paper
• Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007.

  2010cited by this paper
• The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007.

  2010cited by this paper
• Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

  2007cited by this paper
• Sexually transmitted diseases treatment guidelines, 2006.

  2006cited by this paper
• Trends in antimicrobial resistance

  2006cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.

  2004cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.

  2004cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

  2002cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

  2002cited by this paper
• Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999, and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999

  2001cited by this paper
• Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.

  2000cited by this paper
• Completeness of and duration of time before treatment after screening women for Chlamydia trachomatis infections.

  1999cited by this paper
• Fluoroquinolone resistance in Neisseria gonorrhoeae.

  1997cited by this paper
• Sexually transmitted disease surveillance.

  1982cited by this paper

• The distribution of antibiotic use and its association with antibiotic resistance

  2018cites this paper
• Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.

  2018cites this paper
• Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use

  2018cites this paper
• Relevance of healthcare reimbursement data to monitor syphilis epidemic: an alternative surveillance through the national health insurance database in France, 2011–2013

  2018cites this paper
• The use of interrupted time series for the evaluation of public health interventions

  2018cites this paper
• The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis

  2017cites this paper
• The Management of Gonococcal Infections and the Development and Use of Treatment Guidelines

  2016cites this paper